Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma

• Published in: Modern pathology Vol. 34; no. 11; pp. 2071 - 2079
• Main Authors: Murakami, Kosuke, Kanto, Akiko, Sakai, Kazuko, Miyagawa, Chiho, Takaya, Hisamitsu, Nakai, Hidekatsu, Kotani, Yasushi, Nishio, Kazuto, Matsumura, Noriomi
• Format: Journal Article
• Language: English
• Published: New York Elsevier Inc 01.11.2021; Nature Publishing Group US; Elsevier Limited
• Subjects: 45/77; 631/67/1517/1709; 631/67/395; Adenocarcinoma, Clear Cell - genetics; Adenocarcinoma, Clear Cell - pathology; Adult; Biomarkers, Tumor - genetics; Class I Phosphatidylinositol 3-Kinases - genetics; Cysts; DNA Mutational Analysis; Early Detection of Cancer; Endometriosis; Endometriosis - genetics; Endometrium; Endometrium - metabolism; Endometrium - pathology; Female; Gene frequency; Glands; Humans; Laboratory Medicine; Medicine; Medicine & Public Health; Middle Aged; Mutation; Mutation - genetics; Mutation hot spots; Ovarian cancer; Ovarian carcinoma; Ovarian Neoplasms - genetics; Ovarian Neoplasms - pathology; Paraffin; Pathology; Polymerase Chain Reaction; Stroma; Tumors
• ISSN: 0893-3952; 1530-0285
• DOI: 10.1038/s41379-021-00861-3

Recent studies have reported cancer-associated mutations in normal endometrium. Mutations in eutopic endometrium may lead to endometriosis and endometriosis-associated ovarian cancer. We investigated PIK3CA mutations (PIK3CAm) for three hotspots (E542K, E545K, H1047R) in eutopic endometrium in patients with ovarian cancer and endometriosis from formalin-fixed paraffin-embedded specimens by laser-capture microdissection and droplet digital PCR. The presence of PIK3CAm in eutopic endometrial glands with mutant allele frequency ≥ 15% were as follows: ovarian clear cell carcinoma (OCCC) with PIK3CAm in tumors, 20/300 hotspots in 11/14 cases; OCCC without PIK3CAm, 42/78 hotspots in 11/12 cases; high-grade serous ovarian carcinoma, 8/45 hotspots in 3/5 cases; and endometriotic cysts, 5/63 hotspots in 5/6 cases. These rates were more frequent than in noncancer nonendometriosis controls (7/309 hotspots in 5/17 cases). In OCCC without PIK3CAm, 7/12 (58%) cases showed multiple hotspot mutations in the same eutopic endometrial glands. In 3/54 (5.6%) cases, PIK3CAm was found in eutopic endometrial stroma. Multisampling of the OCCC tumors with PIK3CAm showed intratumor heterogeneity in three of eight cases. In two cases, PIK3CAm was detected in the stromal component of the tumor. Homogenous PIK3CAm in the epithelial component of the tumor matched the mutation in eutopic endometrial glands in only one case. Eutopic endometrial glands in ovarian cancer and endometriosis show high frequency of PIK3CAm that is not consistent with tumors, and multiple hotspot mutations are often found in the same glands. While the mutations identified in eutopic endometrium may not be driver mutations in the patient's cancer, these are still driver mutations but this specific clone has not undergone the requisite steps for the development of cancer.